Process for the preparation of muscarinic receptor antagonist
WO2012046253A2
Process for preparation of n-[2-(7-methoxy-1-naphtityl)ethyl] acetamide and its novel crystalline forms
WO2011148392A1
Process for the preparation of (2s,4s,5s,7s)-n-(2-carbamyl-2- methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3- methoxypropoxy)phenyl]-octanamide hemifumarate and its intermediates thereof
WO2011138795A2
Process for preparing (s)-10-acetoxy-10,11-dihydro-5h-dibenz[b,f] azepine-5-carboxamide
WO2011128911A2
Improved process for ll-[(z)-3-(dimethylamino)propyiidenel-6-ll- dihydrodibenz[b,el oxepin-2-aceticacid
WO2011101861A1
Process for preparation of dpp-iv inhibitors
WO2011021216A2
Improved process for preparing 4-(l, l-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2' -bipyrimid in]-4-yl]benzene sulfonamide
WO2011021214A2
Improved process for preparing (s)-2-amino-4, 5, 6, 7-tetrahydro-6-(propylamino)benzothiazole and its dhtydrochloride monohydrate
WO2010122578A2
Process for preparation of sitagliptin and its intermediates
WO2010113183A2
Process for the preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl] pyrrolidine and its pharmaceutically acceptable salts
WO2010095144A2
Process for preparation of proton pump inhibitors
WO2010089770A2
Processes for preparing pitavas tatin, intermediates and pharmaceutically acceptable salts thereof
WO2010089764A2
Improved process for preparation of nebivolol hydrochloride
WO2009139002A2
An improved process for the preparation of solifenacin and its pharmaceutically acceptable salts thereof
